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Mesenchymal stem cells have been increasingly introduced to have great potential in 
regenerative medicine, immunotherapy, and gene therapy due to their unique properties of 
self-renewal and differentiation into multiple cell lineages. Studies have shown that these 
properties may be limited and changed by senescence-associated growth arrest under 
different culture conditions. This study aimed to present the ability of some growth factors on 
human umbilical cord mesenchymal (hUCM) cells expansion and telomerase activity. To 
optimize hUCM cell growth, epidermal growth factor (EGF) and fibroblast growth factor 
(FGF) were utilized in culture media, and the ability of these growth factors on the expression 
of the telomerase reverse transcriptase (TERT) gene and cell cycle phases was investigated. 
TERT mRNA expression increased in the hUCM cells treated by EGF and FGF. So, the 
untreated hUCM cells expressed 30.49 ± 7.15% of TERT, while EGF-treated cells expressed 
51.82 ± 12.96% and FGF-treated cells expressed 33.77 ± 11.55% of TERT. Exposure of 
hUCM cells to EGF or FGF also promoted the progression of cells from G1 to S phase of the 
cell cycle and induced them to decrease the number of cells entering the G2/M phase. Our 
study showed that EGF and, to a lesser extent, FGF amplify the proliferation and expansion 
of hUCM cells. 
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